Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age.

BACKGROUND alpha(1)-adrenergic receptors (alpha(1)ARs) regulate blood pressure, regional vascular resistance, and venous capacitance; the exact subtype (alpha(1a), alpha(1b), alpha(1 d)) mediating these effects is unknown and varies with species studied. In order to understand mechanisms underlying cardiovascular responses to acute stress and chronic catecholamine exposure (as seen with aging), we tested two hypotheses: (1) human alpha(1)AR subtype expression differs with vascular bed, and (2) age influences human vascular alpha(1)AR subtype expression. METHODS AND RESULTS Five hundred vessels from 384 patients were examined for alpha(1)AR subtype distribution at mRNA and protein levels (RNase protection assays, ligand binding, contraction assays). Overall vessel alpha(1)AR density is 16+/-2.3fmol/mg total protein. alpha(1a)AR predominates in arteries at mRNA (P<0.001) and protein (P<0.05) levels; all 3 subtypes are present in veins. Furthermore, alpha(1)AR mRNA subtype expression varies with vessel bed (alpha(1a) higher in splanchnic versus central arteries, P<0.05); competition analysis (selected vessels) and functional assays demonstrate alpha(1a) and alpha(1b)-mediated mammary artery contraction. Overall alpha(1)AR expression doubles with age (<55 versus > or = 65 years) in mammary artery (no change in saphenous vein), accompanied by increased alpha(1b)>alpha(1a) expression (P< = 0.001). CONCLUSIONS Human vascular alpha(1)AR subtype distribution differs from animal models, varies with vessel bed, correlates with contraction in mammary artery, and is modulated by aging. These findings provide potential novel targets for therapeutic intervention in many clinical settings.

[1]  C. D. Richardson,et al.  Alpha1-adrenergic receptor subtypes in human detrusor. , 1998, The Journal of urology.

[2]  G. Tsujimoto,et al.  Effects of quinidine and verapamil on human cardiovascular alpha1-adrenoceptors. , 1998, Circulation.

[3]  M. Piascik,et al.  Immunocytochemical localization of the alpha-1B adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. , 1997, The Journal of pharmacology and experimental therapeutics.

[4]  G. Lembo,et al.  Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Tang,et al.  ALTERATIONS OF mRNA LEVELS OF ai‐ADRENOCEPTOR SUBTYPES WITH MATURATION AND AGEING IN DIFFERENT RAT BLOOD VESSELS , 1997, Clinical and experimental pharmacology & physiology.

[6]  J. Faber,et al.  Alpha1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. , 1997, Molecular pharmacology.

[7]  R. Villalobos-Molina,et al.  Evidence for an age-dependent functional expression of α1D-adrenoceptors in the rat vasculature , 1997 .

[8]  M. Uri,et al.  Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia) , 1997 .

[9]  R. Villalobos-Molina,et al.  Short communication Evidence for an age-dependent functional expression of a -adrenoceptors in the rat vasculature , 1997 .

[10]  B. Hoffman,et al.  Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells. , 1996, The Journal of clinical investigation.

[11]  S. Meretyk,et al.  Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery. , 1996, The Journal of pharmacology and experimental therapeutics.

[12]  R. Graham,et al.  alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. , 1996, Circulation research.

[13]  C. Long,et al.  Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C. , 1996, The Journal of biological chemistry.

[14]  J. Faber,et al.  Different alpha-adrenoceptor subtypes mediate constriction of arterioles and venules. , 1996, The American journal of physiology.

[15]  彰 波田野 Pharmacological evidence of distinct α[1]-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery , 1996 .

[16]  N. Tilakaratne,et al.  The expression of alpha 1 adrenoceptor subtypes changes with age in the rat aorta. , 1995, The Journal of pharmacology and experimental therapeutics.

[17]  M. S. Smith,et al.  The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. , 1995, The Journal of pharmacology and experimental therapeutics.

[18]  R. Lefkowitz,et al.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. , 1995, Pharmacological reviews.

[19]  D J Parry-Smith,et al.  Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. , 1995, The Journal of pharmacology and experimental therapeutics.

[20]  J. Christenson,et al.  Gastrointestinal complications after coronary artery bypass grafting. , 1994, The Journal of thoracic and cardiovascular surgery.

[21]  S. Shreeve,et al.  Identification of the α1C-adrenoceptor in rabbit arteries and the human saphenous vein using the polymerase chain reaction , 1994 .

[22]  W. Meyers,et al.  Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification. , 1994, Molecular pharmacology.

[23]  D. Taylor,et al.  Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat. , 1994, The Journal of pharmacology and experimental therapeutics.

[24]  M. Caron,et al.  Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. , 1994, Molecular pharmacology.

[25]  D. Pennington,et al.  Vascular complications from intraaortic balloons: risk analysis. , 1994, Journal of vascular surgery.

[26]  J. Cunningham,et al.  Acute mesenteric ischemia after cardiopulmonary bypass. , 1993, American journal of surgery.

[27]  P. Reilly,et al.  Vasoactive mediators and splanchnic perfusion , 1993, Critical care medicine.

[28]  J. Wennberg,et al.  Multivariate Prediction of In‐Hospital Mortality Associated With Coronary Artery Bypass Graft Surgery , 1992 .

[29]  鈴木 悦郎 Two pharmacologically distinct α[1]-adrenoceptor subtypes in the contraction of rabbit aorta : each subtype couples with a different Ca[2+] signalling and physiological role , 1991 .

[30]  I. Muramatsu,et al.  Subtypes of alpha 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. , 1991, Japanese journal of pharmacology.

[31]  G. Tsujimoto,et al.  Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role. , 1990, Molecular pharmacology.

[32]  P. Shaul,et al.  Alpha 1-adrenergic receptors in pulmonary and systemic vascular smooth muscle. Alterations with development and pregnancy. , 1990, Circulation research.

[33]  F. Andermann,et al.  Stability of alpha-1 adrenoceptors in surgically excised human brain. , 1986, Life sciences.

[34]  C. Finch,et al.  Extensive postmortem stability of RNA from rat and human brain , 1986, Journal of neuroscience research.

[35]  R. Ruffolo Distribution and function of peripheral α-adrenoceptors in the cardiovascular system , 1985, Pharmacology Biochemistry and Behavior.